The global market for Implantable Neurostimulation Devices was estimated to be worth US$ 6640 million in 2023 and is forecast to a readjusted size of US$ 14080 million by 2030 with a CAGR of 11.2% during the forecast period 2024-2030

Implantable Neurostimulation Devices - Market

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

Global Implantable Neurostimulation Devices key players include Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share over 80%, followed by Europe, and Asia (Ex.China), both have a share about 10 percent.

In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%. And in terms of application, the largest application is Pain Management, followed by Parkinson’s Disease, Epilepsy, Urinary and Fecal Incontinence, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Implantable Neurostimulation Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Implantable Neurostimulation Devices by region & country, by Type, and by Application.

The Implantable Neurostimulation Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Neurostimulation Devices.

Market Segmentation

Scope of Implantable Neurostimulation Devices - Market Report

Report Metric	Details
Report Name	Implantable Neurostimulation Devices - Market
Forecasted market size in 2030	US$ 14080 million
CAGR	11.2%
Forecasted years	2024 - 2030
Segment by Type:	Spinal Cord Stimulation (SCS) Gastric Electric Stimulation (GES) Deep Brain Stimulation (DBS) Sacral Nerve Stimulation (SNS) Vagus Nerve Stimulation (VNS) Others
Segment by Application	Pain Management Parkinson's Disease Urinary and Fecal Incontinence Epilepsy Gastroparesis Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Medtronic, Boston Scientific, St. Jude Medical (Abbott), LivaNova, Nevro, NeuroPace, Beijing Pins, Synapse Biomedical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Implantable Neurostimulation Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Implantable Neurostimulation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Implantable Neurostimulation Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Implantable Neurostimulation Devices - Market size in 2030?

Ans: The Implantable Neurostimulation Devices - Market size in 2030 will be US$ 14080 million.

What is the market share of major companies in Implantable Neurostimulation Devices - Market?

Ans: Global top three manufacturers hold a share over 75%.

What is the Implantable Neurostimulation Devices - Market share by type?

Ans: In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%.

Who are the main players in the Implantable Neurostimulation Devices - Market report?

Ans: The main players in the Implantable Neurostimulation Devices - Market are Medtronic, Boston Scientific, St. Jude Medical (Abbott), LivaNova, Nevro, NeuroPace, Beijing Pins, Synapse Biomedical

What are the Application segmentation covered in the Implantable Neurostimulation Devices - Market report?

Ans: The Applications covered in the Implantable Neurostimulation Devices - Market report are Pain Management, Parkinson's Disease, Urinary and Fecal Incontinence, Epilepsy, Gastroparesis, Others

What are the Type segmentation covered in the Implantable Neurostimulation Devices - Market report?

Ans: The Types covered in the Implantable Neurostimulation Devices - Market report are Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Others

1 Market Overview

1.1 Implantable Neurostimulation Devices Product Introduction

1.2 Global Implantable Neurostimulation Devices Market Size Forecast

1.2.1 Global Implantable Neurostimulation Devices Sales Value (2019-2030)

1.2.2 Global Implantable Neurostimulation Devices Sales Volume (2019-2030)

1.2.3 Global Implantable Neurostimulation Devices Sales Price (2019-2030)

1.3 Implantable Neurostimulation Devices Market Trends & Drivers

1.3.1 Implantable Neurostimulation Devices Industry Trends

1.3.2 Implantable Neurostimulation Devices Market Drivers & Opportunity

1.3.3 Implantable Neurostimulation Devices Market Challenges

1.3.4 Implantable Neurostimulation Devices Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Implantable Neurostimulation Devices Players Revenue Ranking (2023)

2.2 Global Implantable Neurostimulation Devices Revenue by Company (2019-2024)

2.3 Global Implantable Neurostimulation Devices Players Sales Volume Ranking (2023)

2.4 Global Implantable Neurostimulation Devices Sales Volume by Company Players (2019-2024)

2.5 Global Implantable Neurostimulation Devices Average Price by Company (2019-2024)

2.6 Key Manufacturers Implantable Neurostimulation Devices Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Implantable Neurostimulation Devices Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Implantable Neurostimulation Devices

2.9 Implantable Neurostimulation Devices Market Competitive Analysis

2.9.1 Implantable Neurostimulation Devices Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Implantable Neurostimulation Devices Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Neurostimulation Devices as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Spinal Cord Stimulation (SCS)

3.1.2 Gastric Electric Stimulation (GES)

3.1.3 Deep Brain Stimulation (DBS)

3.1.4 Sacral Nerve Stimulation (SNS)

3.1.5 Vagus Nerve Stimulation (VNS)

3.1.6 Others

3.2 Global Implantable Neurostimulation Devices Sales Value by Type

3.2.1 Global Implantable Neurostimulation Devices Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Implantable Neurostimulation Devices Sales Value, by Type (2019-2030)

3.2.3 Global Implantable Neurostimulation Devices Sales Value, by Type (%) (2019-2030)

3.3 Global Implantable Neurostimulation Devices Sales Volume by Type

3.3.1 Global Implantable Neurostimulation Devices Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Implantable Neurostimulation Devices Sales Volume, by Type (2019-2030)

3.3.3 Global Implantable Neurostimulation Devices Sales Volume, by Type (%) (2019-2030)

3.4 Global Implantable Neurostimulation Devices Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pain Management

4.1.2 Parkinson's Disease

4.1.3 Urinary and Fecal Incontinence

4.1.4 Epilepsy

4.1.5 Gastroparesis

4.1.6 Others

4.2 Global Implantable Neurostimulation Devices Sales Value by Application

4.2.1 Global Implantable Neurostimulation Devices Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Implantable Neurostimulation Devices Sales Value, by Application (2019-2030)

4.2.3 Global Implantable Neurostimulation Devices Sales Value, by Application (%) (2019-2030)

4.3 Global Implantable Neurostimulation Devices Sales Volume by Application

4.3.1 Global Implantable Neurostimulation Devices Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Implantable Neurostimulation Devices Sales Volume, by Application (2019-2030)

4.3.3 Global Implantable Neurostimulation Devices Sales Volume, by Application (%) (2019-2030)

4.4 Global Implantable Neurostimulation Devices Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Implantable Neurostimulation Devices Sales Value by Region

5.1.1 Global Implantable Neurostimulation Devices Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Implantable Neurostimulation Devices Sales Value by Region (2019-2024)

5.1.3 Global Implantable Neurostimulation Devices Sales Value by Region (2025-2030)

5.1.4 Global Implantable Neurostimulation Devices Sales Value by Region (%), (2019-2030)

5.2 Global Implantable Neurostimulation Devices Sales Volume by Region

5.2.1 Global Implantable Neurostimulation Devices Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Implantable Neurostimulation Devices Sales Volume by Region (2019-2024)

5.2.3 Global Implantable Neurostimulation Devices Sales Volume by Region (2025-2030)

5.2.4 Global Implantable Neurostimulation Devices Sales Volume by Region (%), (2019-2030)

5.3 Global Implantable Neurostimulation Devices Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Implantable Neurostimulation Devices Sales Value, 2019-2030

5.4.2 North America Implantable Neurostimulation Devices Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Implantable Neurostimulation Devices Sales Value, 2019-2030

5.5.2 Europe Implantable Neurostimulation Devices Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Implantable Neurostimulation Devices Sales Value, 2019-2030

5.6.2 Asia Pacific Implantable Neurostimulation Devices Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Implantable Neurostimulation Devices Sales Value, 2019-2030

5.7.2 South America Implantable Neurostimulation Devices Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Implantable Neurostimulation Devices Sales Value, 2019-2030

5.8.2 Middle East & Africa Implantable Neurostimulation Devices Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Implantable Neurostimulation Devices Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Implantable Neurostimulation Devices Sales Value

6.2.1 Key Countries/Regions Implantable Neurostimulation Devices Sales Value, 2019-2030

6.2.2 Key Countries/Regions Implantable Neurostimulation Devices Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Implantable Neurostimulation Devices Sales Value, 2019-2030

6.3.2 United States Implantable Neurostimulation Devices Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Implantable Neurostimulation Devices Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Implantable Neurostimulation Devices Sales Value, 2019-2030

6.4.2 Europe Implantable Neurostimulation Devices Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Implantable Neurostimulation Devices Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Implantable Neurostimulation Devices Sales Value, 2019-2030

6.5.2 China Implantable Neurostimulation Devices Sales Value by Type (%), 2023 VS 2030

6.5.3 China Implantable Neurostimulation Devices Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Implantable Neurostimulation Devices Sales Value, 2019-2030

6.6.2 Japan Implantable Neurostimulation Devices Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Implantable Neurostimulation Devices Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Implantable Neurostimulation Devices Sales Value, 2019-2030

6.7.2 South Korea Implantable Neurostimulation Devices Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Implantable Neurostimulation Devices Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Implantable Neurostimulation Devices Sales Value, 2019-2030

6.8.2 Southeast Asia Implantable Neurostimulation Devices Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Implantable Neurostimulation Devices Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Implantable Neurostimulation Devices Sales Value, 2019-2030

6.9.2 India Implantable Neurostimulation Devices Sales Value by Type (%), 2023 VS 2030

6.9.3 India Implantable Neurostimulation Devices Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Medtronic

7.1.1 Medtronic Company Information

7.1.2 Medtronic Introduction and Business Overview

7.1.3 Medtronic Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Medtronic Implantable Neurostimulation Devices Product Offerings

7.1.5 Medtronic Recent Development

7.2 Boston Scientific

7.2.1 Boston Scientific Company Information

7.2.2 Boston Scientific Introduction and Business Overview

7.2.3 Boston Scientific Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Boston Scientific Implantable Neurostimulation Devices Product Offerings

7.2.5 Boston Scientific Recent Development

7.3 St. Jude Medical (Abbott)

7.3.1 St. Jude Medical (Abbott) Company Information

7.3.2 St. Jude Medical (Abbott) Introduction and Business Overview

7.3.3 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)

7.3.4 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Product Offerings

7.3.5 St. Jude Medical (Abbott) Recent Development

7.4 LivaNova

7.4.1 LivaNova Company Information

7.4.2 LivaNova Introduction and Business Overview

7.4.3 LivaNova Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)

7.4.4 LivaNova Implantable Neurostimulation Devices Product Offerings

7.4.5 LivaNova Recent Development

7.5 Nevro

7.5.1 Nevro Company Information

7.5.2 Nevro Introduction and Business Overview

7.5.3 Nevro Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Nevro Implantable Neurostimulation Devices Product Offerings

7.5.5 Nevro Recent Development

7.6 NeuroPace

7.6.1 NeuroPace Company Information

7.6.2 NeuroPace Introduction and Business Overview

7.6.3 NeuroPace Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)

7.6.4 NeuroPace Implantable Neurostimulation Devices Product Offerings

7.6.5 NeuroPace Recent Development

7.7 Beijing Pins

7.7.1 Beijing Pins Company Information

7.7.2 Beijing Pins Introduction and Business Overview

7.7.3 Beijing Pins Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Beijing Pins Implantable Neurostimulation Devices Product Offerings

7.7.5 Beijing Pins Recent Development

7.8 Synapse Biomedical

7.8.1 Synapse Biomedical Company Information

7.8.2 Synapse Biomedical Introduction and Business Overview

7.8.3 Synapse Biomedical Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Synapse Biomedical Implantable Neurostimulation Devices Product Offerings

7.8.5 Synapse Biomedical Recent Development

8 Industry Chain Analysis

8.1 Implantable Neurostimulation Devices Industrial Chain

8.2 Implantable Neurostimulation Devices Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Implantable Neurostimulation Devices Sales Model

8.5.2 Sales Channel

8.5.3 Implantable Neurostimulation Devices Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

St. Jude Medical (Abbott)

List of Tables

Table 1. Implantable Neurostimulation Devices Market Trends

Table 2. Implantable Neurostimulation Devices Market Drivers & Opportunity

Table 3. Implantable Neurostimulation Devices Market Challenges

Table 4. Implantable Neurostimulation Devices Market Restraints

Table 5. Global Implantable Neurostimulation Devices Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Implantable Neurostimulation Devices Revenue Market Share by Company (2019-2024)

Table 7. Global Implantable Neurostimulation Devices Sales Volume by Company (2019-2024) & (Units)

Table 8. Global Implantable Neurostimulation Devices Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Implantable Neurostimulation Devices Price by Company (2019-2024) & (K USD/Unit)

Table 10. Key Manufacturers Implantable Neurostimulation Devices Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Implantable Neurostimulation Devices Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Implantable Neurostimulation Devices

Table 13. Global Implantable Neurostimulation Devices Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Neurostimulation Devices as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Implantable Neurostimulation Devices Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Implantable Neurostimulation Devices Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Implantable Neurostimulation Devices Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Implantable Neurostimulation Devices Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Implantable Neurostimulation Devices Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Implantable Neurostimulation Devices Sales Volume by Type: 2019 VS 2023 VS 2030 (Units)

Table 22. Global Implantable Neurostimulation Devices Sales Volume by Type (2019-2024) & (Units)

Table 23. Global Implantable Neurostimulation Devices Sales Volume by Type (2025-2030) & (Units)

Table 24. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Implantable Neurostimulation Devices Price by Type (2019-2024) & (K USD/Unit)

Table 27. Global Implantable Neurostimulation Devices Price by Type (2025-2030) & (K USD/Unit)

Table 28. Global Implantable Neurostimulation Devices Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Implantable Neurostimulation Devices Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Implantable Neurostimulation Devices Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Implantable Neurostimulation Devices Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Implantable Neurostimulation Devices Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Implantable Neurostimulation Devices Sales Volume by Application: 2019 VS 2023 VS 2030 (Units)

Table 34. Global Implantable Neurostimulation Devices Sales Volume by Application (2019-2024) & (Units)

Table 35. Global Implantable Neurostimulation Devices Sales Volume by Application (2025-2030) & (Units)

Table 36. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Implantable Neurostimulation Devices Price by Application (2019-2024) & (K USD/Unit)

Table 39. Global Implantable Neurostimulation Devices Price by Application (2025-2030) & (K USD/Unit)

Table 40. Global Implantable Neurostimulation Devices Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Implantable Neurostimulation Devices Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Implantable Neurostimulation Devices Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Implantable Neurostimulation Devices Sales Value by Region (2019-2024) & (%)

Table 44. Global Implantable Neurostimulation Devices Sales Value by Region (2025-2030) & (%)

Table 45. Global Implantable Neurostimulation Devices Sales Volume by Region (Units): 2019 VS 2023 VS 2030

Table 46. Global Implantable Neurostimulation Devices Sales Volume by Region (2019-2024) & (Units)

Table 47. Global Implantable Neurostimulation Devices Sales Volume by Region (2025-2030) & (Units)

Table 48. Global Implantable Neurostimulation Devices Sales Volume by Region (2019-2024) & (%)

Table 49. Global Implantable Neurostimulation Devices Sales Volume by Region (2025-2030) & (%)

Table 50. Global Implantable Neurostimulation Devices Average Price by Region (2019-2024) & (K USD/Unit)

Table 51. Global Implantable Neurostimulation Devices Average Price by Region (2025-2030) & (K USD/Unit)

Table 52. Key Countries/Regions Implantable Neurostimulation Devices Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Implantable Neurostimulation Devices Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Implantable Neurostimulation Devices Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Implantable Neurostimulation Devices Sales Volume, (2019-2024) & (Units)

Table 56. Key Countries/Regions Implantable Neurostimulation Devices Sales Volume, (2025-2030) & (Units)

Table 57. Medtronic Company Information

Table 58. Medtronic Introduction and Business Overview

Table 59. Medtronic Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 60. Medtronic Implantable Neurostimulation Devices Product Offerings

Table 61. Medtronic Recent Development

Table 62. Boston Scientific Company Information

Table 63. Boston Scientific Introduction and Business Overview

Table 64. Boston Scientific Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 65. Boston Scientific Implantable Neurostimulation Devices Product Offerings

Table 66. Boston Scientific Recent Development

Table 67. St. Jude Medical (Abbott) Company Information

Table 68. St. Jude Medical (Abbott) Introduction and Business Overview

Table 69. St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 70. St. Jude Medical (Abbott) Implantable Neurostimulation Devices Product Offerings

Table 71. St. Jude Medical (Abbott) Recent Development

Table 72. LivaNova Company Information

Table 73. LivaNova Introduction and Business Overview

Table 74. LivaNova Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 75. LivaNova Implantable Neurostimulation Devices Product Offerings

Table 76. LivaNova Recent Development

Table 77. Nevro Company Information

Table 78. Nevro Introduction and Business Overview

Table 79. Nevro Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 80. Nevro Implantable Neurostimulation Devices Product Offerings

Table 81. Nevro Recent Development

Table 82. NeuroPace Company Information

Table 83. NeuroPace Introduction and Business Overview

Table 84. NeuroPace Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 85. NeuroPace Implantable Neurostimulation Devices Product Offerings

Table 86. NeuroPace Recent Development

Table 87. Beijing Pins Company Information

Table 88. Beijing Pins Introduction and Business Overview

Table 89. Beijing Pins Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 90. Beijing Pins Implantable Neurostimulation Devices Product Offerings

Table 91. Beijing Pins Recent Development

Table 92. Synapse Biomedical Company Information

Table 93. Synapse Biomedical Introduction and Business Overview

Table 94. Synapse Biomedical Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 95. Synapse Biomedical Implantable Neurostimulation Devices Product Offerings

Table 96. Synapse Biomedical Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Implantable Neurostimulation Devices Downstream Customers

Table 100. Implantable Neurostimulation Devices Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Implantable Neurostimulation Devices Product Picture

Figure 2. Global Implantable Neurostimulation Devices Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Implantable Neurostimulation Devices Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Implantable Neurostimulation Devices Sales Volume (2019-2030) & (Units)

Figure 5. Global Implantable Neurostimulation Devices Sales Price (2019-2030) & (K USD/Unit)

Figure 6. Implantable Neurostimulation Devices Report Years Considered

Figure 7. Global Implantable Neurostimulation Devices Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Implantable Neurostimulation Devices Players Sales Volume Ranking (2023) & (Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Implantable Neurostimulation Devices Revenue in 2023

Figure 10. Implantable Neurostimulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Spinal Cord Stimulation (SCS) Picture

Figure 12. Gastric Electric Stimulation (GES) Picture

Figure 13. Deep Brain Stimulation (DBS) Picture

Figure 14. Sacral Nerve Stimulation (SNS) Picture

Figure 15. Vagus Nerve Stimulation (VNS) Picture

Figure 16. Others Picture

Figure 17. Global Implantable Neurostimulation Devices Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Implantable Neurostimulation Devices Sales Value Market Share by Type, 2023 & 2030

Figure 19. Global Implantable Neurostimulation Devices Sales Volume by Type (2019 VS 2023 VS 2030) & (Units)

Figure 20. Global Implantable Neurostimulation Devices Sales Volume Market Share by Type, 2023 & 2030

Figure 21. Global Implantable Neurostimulation Devices Price by Type (2019-2030) & (K USD/Unit)

Figure 22. Product Picture of Pain Management

Figure 23. Product Picture of Parkinson's Disease

Figure 24. Product Picture of Urinary and Fecal Incontinence

Figure 25. Product Picture of Epilepsy

Figure 26. Product Picture of Gastroparesis

Figure 27. Product Picture of Others

Figure 28. Global Implantable Neurostimulation Devices Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 29. Global Implantable Neurostimulation Devices Sales Value Market Share by Application, 2023 & 2030

Figure 30. Global Implantable Neurostimulation Devices Sales Volume by Application (2019 VS 2023 VS 2030) & (Units)

Figure 31. Global Implantable Neurostimulation Devices Sales Volume Market Share by Application, 2023 & 2030

Figure 32. Global Implantable Neurostimulation Devices Price by Application (2019-2030) & (K USD/Unit)

Figure 33. North America Implantable Neurostimulation Devices Sales Value (2019-2030) & (US$ Million)

Figure 34. North America Implantable Neurostimulation Devices Sales Value by Country (%), 2023 VS 2030

Figure 35. Europe Implantable Neurostimulation Devices Sales Value (2019-2030) & (US$ Million)

Figure 36. Europe Implantable Neurostimulation Devices Sales Value by Country (%), 2023 VS 2030

Figure 37. Asia Pacific Implantable Neurostimulation Devices Sales Value (2019-2030) & (US$ Million)

Figure 38. Asia Pacific Implantable Neurostimulation Devices Sales Value by Country (%), 2023 VS 2030

Figure 39. South America Implantable Neurostimulation Devices Sales Value (2019-2030) & (US$ Million)

Figure 40. South America Implantable Neurostimulation Devices Sales Value by Country (%), 2023 VS 2030

Figure 41. Middle East & Africa Implantable Neurostimulation Devices Sales Value (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Implantable Neurostimulation Devices Sales Value by Country (%), 2023 VS 2030

Figure 43. Key Countries/Regions Implantable Neurostimulation Devices Sales Value (%), (2019-2030)

Figure 44. Key Countries/Regions Implantable Neurostimulation Devices Sales Volume (%), (2019-2030)

Figure 45. United States Implantable Neurostimulation Devices Sales Value, (2019-2030) & (US$ Million)

Figure 46. United States Implantable Neurostimulation Devices Sales Value by Type (%), 2023 VS 2030

Figure 47. United States Implantable Neurostimulation Devices Sales Value by Application (%), 2023 VS 2030

Figure 48. Europe Implantable Neurostimulation Devices Sales Value, (2019-2030) & (US$ Million)

Figure 49. Europe Implantable Neurostimulation Devices Sales Value by Type (%), 2023 VS 2030

Figure 50. Europe Implantable Neurostimulation Devices Sales Value by Application (%), 2023 VS 2030

Figure 51. China Implantable Neurostimulation Devices Sales Value, (2019-2030) & (US$ Million)

Figure 52. China Implantable Neurostimulation Devices Sales Value by Type (%), 2023 VS 2030

Figure 53. China Implantable Neurostimulation Devices Sales Value by Application (%), 2023 VS 2030

Figure 54. Japan Implantable Neurostimulation Devices Sales Value, (2019-2030) & (US$ Million)

Figure 55. Japan Implantable Neurostimulation Devices Sales Value by Type (%), 2023 VS 2030

Figure 56. Japan Implantable Neurostimulation Devices Sales Value by Application (%), 2023 VS 2030

Figure 57. South Korea Implantable Neurostimulation Devices Sales Value, (2019-2030) & (US$ Million)

Figure 58. South Korea Implantable Neurostimulation Devices Sales Value by Type (%), 2023 VS 2030

Figure 59. South Korea Implantable Neurostimulation Devices Sales Value by Application (%), 2023 VS 2030

Figure 60. Southeast Asia Implantable Neurostimulation Devices Sales Value, (2019-2030) & (US$ Million)

Figure 61. Southeast Asia Implantable Neurostimulation Devices Sales Value by Type (%), 2023 VS 2030

Figure 62. Southeast Asia Implantable Neurostimulation Devices Sales Value by Application (%), 2023 VS 2030

Figure 63. India Implantable Neurostimulation Devices Sales Value, (2019-2030) & (US$ Million)

Figure 64. India Implantable Neurostimulation Devices Sales Value by Type (%), 2023 VS 2030

Figure 65. India Implantable Neurostimulation Devices Sales Value by Application (%), 2023 VS 2030

Figure 66. Implantable Neurostimulation Devices Industrial Chain

Figure 67. Implantable Neurostimulation Devices Manufacturing Cost Structure

Figure 68. Channels of Distribution (Direct Sales, and Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions